SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

08 Aug 2025 Evaluate
The sales surged to Rs. 1864.79 millions, up 35.22% for the June 2025 quarter as against Rs. 1379.08 millions during the corresponding quarter previous year.A slender decline of -12.69% was recorded to Rs. 83.01  millions from Rs. 95.08 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 136.79 millions from 142.87 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1864.79 1379.08 35.22 1864.79 1379.08 35.22 6615.15 6470.04 2.24
Other Income 33.88 37.19 -8.90 33.88 37.19 -8.90 94.55 120.98 -21.85
PBIDT 136.79 142.87 -4.26 136.79 142.87 -4.26 703.64 872.47 -19.35
Interest 2.11 1.42 48.59 2.11 1.42 48.59 6.19 3.54 74.86
PBDT 134.68 141.45 -4.79 134.68 141.45 -4.79 697.45 868.93 -19.73
Depreciation 25.15 18.80 33.78 25.15 18.80 33.78 87.39 85.84 1.81
PBT 109.53 122.65 -10.70 109.53 122.65 -10.70 610.06 783.09 -22.10
TAX 26.52 27.57 -3.81 26.52 27.57 -3.81 136.53 182.52 -25.20
Deferred Tax 1.62 0.37 337.84 1.62 0.37 337.84 -16.52 3.59 -560.17
PAT 83.01 95.08 -12.69 83.01 95.08 -12.69 473.53 600.57 -21.15
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 7.34 10.36 -29.19 7.34 10.36 -29.19 10.64 13.48 -21.12

Anuh Pharma Share Price

78.21 -1.03 (-1.30%)
13-Apr-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.30
Dr. Reddys Lab 1226.60
Cipla 1218.30
Zydus Lifesciences 926.35
Lupin 2333.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×